Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Otsuka-Pharmaceutical-Development-&-Commercialization"

1 News Found

Otsuka files FDA application for first-in-class ADHD drug
Clinical Trials | November 27, 2025

Otsuka files FDA application for first-in-class ADHD drug

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor